Baird analyst Eric Coldwell raised the firm’s price target on Cardinal Health to $126 from $109 and keeps an Outperform rating on the shares. The firm said they posted another beat and raise, strong and diversified core growth, fantastic cash flow and balance sheet supporting healthy dividend and repos, majority of offerings work and working well and Medical Improvement Plan on track.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CAH:
- Options Volatility and Implied Earnings Moves Today, November 03, 2023
- Cardinal Health raises FY24 EPS view to $6.75-$7.00 from $6.50-$6.75
- Cardinal Health reports Q1 adjusted EPS $1.73, consensus $1.40
- Cardinal Health Reports First Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook
- Notable companies reporting before tomorrow’s open
